EUVIMEDEUVIMED entdecken
Crossref

Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets

Atsushi Ohta, Mikimasa Tanada iD, Shojiro Shinohara, Yuya Morita, Kazuhiko Nakano, Yusuke Yamagishi, Ryusuke Takano iD, Shiori Kariyuki, Takeo Iida, Atsushi Matsuo, Kazuhisa Ozeki, Takashi Emura und 35 weitere

Journal of the American Chemical Society · 08.11.2023 · 145 (44) · 24035-24051

DOI: 10.1021/jacs.3c07145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.10.2023. Verfasst von Atsushi Ohta und 46 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Chugai Pharmaceutical Co., Ltd., 216, Totsuka-cho,Totsuka-ku, Yokohama 244-8602, Kanagawa, Japan. Hauptthemen laut MEDLINE: Peptides, Cyclic. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptides, Cyclic

Substanzen

Peptides, Cyclic

Autor:innen und Institutionen

  • Research Division, Chugai Pharmaceutical Co., Ltd., 216, Totsuka-cho,Totsuka-ku, Yokohama 244-8602, Kanagawa, Japan.

ORCID-Profile: Mikimasa Tanada, Ryusuke Takano, Yoshikazu Nishimura, Kenichi Nomura, Toshiya Ito

Zitieren

APA

Ohta, A., Tanada, M., Shinohara, S., Morita, Y., Nakano, K., Yamagishi, Y., Takano, R., Kariyuki, S., Iida, T., Matsuo, A., Ozeki, K., Emura, T., Sakurai, Y., Takano, K., Higashida, A., Kojima, M., Muraoka, T., Takeyama, R., Kato, T., …, & Iikura, H. (2023). Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets. Journal of the American Chemical Society, 145(44), 24035-24051. https://doi.org/10.1021/jacs.3c07145

Vancouver

Ohta A, Tanada M, Shinohara S, Morita Y, Nakano K, Yamagishi Y, et al. Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets. Journal of the American Chemical Society. 2023;145(44):24035-24051. doi:10.1021/jacs.3c07145

BibTeX
@article{Ohta2023,
  author = {Ohta, Atsushi and Tanada, Mikimasa and Shinohara, Shojiro and Morita, Yuya and Nakano, Kazuhiko and Yamagishi, Yusuke and Takano, Ryusuke and Kariyuki, Shiori and Iida, Takeo and Matsuo, Atsushi and Ozeki, Kazuhisa and Emura, Takashi and Sakurai, Yuuji and Takano, Koji and Higashida, Atsuko and Kojima, Miki and Muraoka, Terushige and Takeyama, Ryuuichi and Kato, Tatsuya and Kimura, Kaori and Ogawa, Kotaro and Ohara, Kazuhiro and Tanaka, Shota and Kikuchi, Yasufumi and Hisada, Nozomi and Hayashi, Ryuji and Nishimura, Yoshikazu and Nomura, Kenichi and Tachibana, Tatsuhiko and Irie, Machiko and Kawada, Hatsuo and Torizawa, Takuya and Murao, Naoaki and Kotake, Tomoya and Tanaka, Masahiko and Ishikawa, Shiho and Miyake, Taiji and Tamiya, Minoru and Arai, Masako and Chiyoda, Aya and Akai, Sho and Sase, Hitoshi and Kuramoto, Shino and Ito, Toshiya and Shiraishi, Takuya and Kojima, Tetsuo and Iikura, Hitoshi},
  title = {Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  volume = {145},
  number = {44},
  pages = {24035--24051},
  doi = {10.1021/jacs.3c07145}
}
Kostenlos starten →